No previous studies have compared radiosensitization by AZD7762 and other inhibitors, and we found that it is a better radiosensitizer of rectal cancer cells than inhibitors of other proteins involved in the response to genotoxic agents, as well as other inhibitors of the ATM-Chk1/2 pathway. The gene discussed is ATM; the disease is rectal cancer.